We recently published a list of 12 Best Multibagger Stocks to Buy in 2025. In this article, we are going to take a look at ...

Investing.com -- Grizzly Research has shorted GeneDx, a genetic testing company, accusing them of widespread fraud. GeneDx specializes in advanced genomic testing, with a focus on rare and ultra ...

GeneDx recognized for its innovative approach to accelerating genetic diagnosis and transforming the future of healthcare by ending the diagnostic odyssey “Our list of the Most Innovative ...

We recently published a list of 12 High Growth Low Debt Stocks to Invest in Now. In this article, we are going to take a look ...

Victory Capital Management Inc. bought a new position in GeneDx Holdings Corp. (NASDAQ:WGS – Free Report) in the fourth quarter, Holdings Channel reports. The firm bought 2,720 shares of the ...

Reports FY24 revenue $305.5M, consensus $290.82M .”The fourth quarter capped an outstanding year for GeneDx (WGS), as we work to end the diagnostic odyssey with earlier intervention using our ...

GAITHERSBURG, Md., March 13, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today its scientific contributions ...

GAITHERSBURG, Md., March 04, 2025--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, announced today an indication expansion for its ...

GAITHERSBURG, Md.--(BUSINESS WIRE)--GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced Multiscore, an advanced AI-powered decision ...

GeneDx Holdings Corp. (NASDAQ:WGS) Q4 2024 Earnings Call Transcript February 18, 2025 GeneDx Holdings Corp. beats earnings expectations. Reported EPS is $0.62, expectations were $0.04.